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INTRODUCTION:  Solid-cystic  pseudopapillary  tumor  of  the  pancreas  is rare  and  most  commonly  seen  in
young women.  We  present  a young  women  with  solid-cystic  pseudopapillary  tumor  of the  pancreas  and
discuss  the  literature.
PRESENTATION  OF  CASE:  Thirty  nine  years  old  female  patient  with  a mass  about  12 cm in the  pancreas
with  splenic  invasion  seen  in  our  clinic.  After  having  CT  and  PET-CT  view,  patient  underwent  surgery.
Distal  pancreatectomy  with  mass  excision  and  splenectomy  was  performed.  Microscopic  examination
result  was  solid  cystic  pseudopapillary  tumor  with  spleen  invasion.
DISCUSSION:  Solid-cystic  pseudopapillary  tumor  of the  pancreas  has  cystic  solid  pseudopapillary  struc-
tures.  Prognosis  of  tumor  is  better  than  other  pancreatic  tumor.  Complete  resection  of  tumor  with  splenic
inclusion  is  surgical  treatment.
CONCLUSION:  In case  of  large  slow  growing  pancreatic  tumor  with  splenic  metastasis,  solid-cystic  pseu-
dopapillary  tumor  of  the pancreas  should  be  considered  in  the  diagnosis.  Complete  surgical  resection
is  associated  with  long-term  survival  even  in  the presence  of  metastatic  disease.  Close  follow-up  is
necessary  after  surgery.
©  2015  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Solid-cystic pseudopapillary tumor of the pancreas (SCPTP) is
a rare tumor which is 0.17–2.7% of pancreatic tumors and cre-
ates low malignancy potential [1]. This tumor was deﬁned by
World Health Organization as pseudopapillary solid neoplasm. His-
tologically, SCPTP has typically short, solid and pseudopapillary
structures. Women  are often affected than men  (8 women/men)
and are very common in the third decade of age. In fact, unlike the
exocrine pancreas tumors, prognosis of metastatic tumors is even
better. Primary and metastatic tumor is excised and recurrence is
rare [2]. A case of SCPTP with splenic involvement is aimed to be
presented with discussion of previous literature.
2. Presentation of case
Thirty nine years old female patient came to our clinic with
complaint of abdominal pain. She had no appetite and weight loss.
On physical examination 10 cm mass in the left upper quadrant
of abdomen with spleen growth was palpated. Only comorbidy of
patient was hypertension. All blood tests and tumor markers were
normal. A 12 cm mass was noticed in the pancreas invading splenic
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with abdominal ultrasound. Computerized tomography showed
12 cm mass in the distal pancreas with splenic invasion (Fig. 1).
Preoperative PET-CT viewed a mass size of 12 cm × 11 cm × 12 cm
in the pancreas starting from left adrenal gland invading the spleen
(SUV max: 12) (Fig. 2). Distal pancreatectomy with mass excision
and splenectomy was  performed (Figs. 3 and 4). Solid and cys-
tic mass macroscopically was covered with ﬁbrous capsule with
nodular structure. Microscopic examination result was solid cystic
pseudopapillary tumor with spleen invasion. Partial internal bleed-
ing, necrosis and mitosis were present in tumor. Patient discharged
without any complication. Patient is well at 8 month postoperative
follow up without tumor recurrence.
3. Discussion
Solid-cystic pseudopapillary tumor of the pancreas appears in
all ages, the female to male ratio of 8.3 and the average age 27-
year-old young women are most affected [3]. Patients are usually
young and compliant with treatment [3,4]. Most patients have
non-speciﬁc symptoms such as mild abdominal pain and gas or
no symptoms. Our patient had abdominal pain for about 2–3
months before the diagnosis. The average tumor size was 9.5 cm
in the literature. The reason for large tumor size was  late diagnosis
and slow-growing pattern [5]. Routine screening US  examinations
are capable of identifying small (<5.0 cm)  SCPTP. These screening
examinations allow diagnosis on the basis of typical imaging
http://dx.doi.org/10.1016/j.ijscr.2015.06.042
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Fig. 1. Computerized tomography of solid-cystic pseudopapillary tumor of the pan-
creas.
Fig. 2. PET-CT view of solid-cystic pseudopapillary tumor of the pancreas.
features, such as a homogeneously hypoechoic mass with a hyper-
echoic rim [6]. Computed tomography of tumor shows the solid
and cystic areas [7]. Magnetic resonance imaging is used to dif-
ferentiate capsular cystic degeneration and bleeding [8]. PET CT
has determined the high FDG uptake (SUV max: 12) in our case. In
a recent study from Korea, Clinical correlations with (18)FDG PET
scan patterns in solid pseudopapillary tumors of the pancreas were
studied. Medical records of 37 patients underwent resection of pan-
creatic solid pseudopapillary tumors and preoperatively evaluated
by (18)F-FDG PET or PET/CT scan were reviewed. They categorized
solid pseudopapillary tumors into ﬁve types: Type I (hot FDG uptake
in the entire tumor portion) was the most frequent (13, 34.2%), fol-
lowed by type IV (focal uptake, 12, 31.6%), II (focal defect, 8, 21.1%),
III (multiple and geographic uptake, 3, 7.9%), and V (total defec-
tive type, 1, 2.6%). The SUVmax in the solid portion of the SPT was
5.3 ± 4.1. The clinical pattern of FDG uptake in SPT was  not associ-
ated with histopathologic features suggesting malignant potential.
They arrived the conclusion that the clinical signiﬁcance of FDG
uptake, glucose metabolism, and clinical usefulness of PET scan in
solid pseudopapillary tumors need to be further investigated, and
thus this tumor remains a surgical enigma [9].
Surgery is an effective treatment method for SCPTP. Publica-
tion with largest series about SCPTP was published in 2005 by
a Papavramidis et al. [1]. 210 articles were published for about
718 patients detected between 1933 and 2003 years. 497 patients
had metastatic disease and 17 (3.4%) of these patients had splenic
involvement. Other major study was published in 2010 by Yu et al.
[3]. In the examination of 492 patients, 4 (0.8%) patients had splenic
involvement. Our patient was presented as SCPTP with splenic
Fig. 3. Solid-cystic pseudopapillary tumor of the pancreas with spleen.
Fig. 4. Solid-cystic pseudopapillary tumor of the pancreas with spleen after com-
plete resection.
involvement. In a retrospective review printed by Memorial Sloan
Kettering Cancer Center [10], Gastric and mixed tumor service,
from January 1985 to July 2000, 24 patients were diagnosed as
having solid-pseudopapillary tumor of the pancreas (0.9%). Twenty
females and four males were identiﬁed, with a median age of 39
years. The median size of the lesions was  8.0 cm (range, 1–20). At a
median follow-up of 8 years, one recurrence occurred in 17 patients
who underwent complete resection. Four patients presented with
synchronous liver metastasis and underwent resection of the pri-
mary tumor and the liver metastasis. Conclusion was that complete
resection is associated with long-term survival even in the presence
of metastatic disease [10]. A multicenter analysis in Korea [11] stud-
ied prognostic factors that predict the malignant behavior of sold
pancreatic tumors (SPTs). Among 351 patients, thirty-four patients
(9.7%) were male, and 317 (90.3%) were female, with a mean age of
36.8 ± 12.4 years, a tumor size larger than 8 cm,  microscopic malig-
nant features, and stage IV were signiﬁcant prognostic factors for
tumor recurrence. Li et al. [12] studied 41 patients were diagnosed
with SPN of the pancreas and underwent surgical resection. The
most common location of SPN was the tail (43.9%). Mean diam-
eters of SPN was  5.5 cm (range, 1.2–14.5 cm). Surgical treatment
included distal pancreatectomy in 21, pancreaticoduodenectomy
in 11, segmental resection of pancreas in 4, enucleation in 2, exci-
sion in 2 and surgical biopsy in 1. They arrived conclusion that
patients diagnosed as SPN should receive surgical resection because
of the excellent prognosis. Closed follow-up is recommended
after surgery, even in patients without pathological malignant
potential.
As a conclusion, in case of slow growing large pancreatic
tumor with splenic involvement SCPTP should be considered in
the diagnosis. SCPTP should receive surgical resection and com-
plete resection is associated with long-term survival even in the
presence of metastatic disease. Close follow-up is necessary after
surgery.
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